+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Thalassemia Market and Competitive Landscape - 2020

  • ID: 5023634
  • Report
  • April 2020
  • Region: Global
  • Fore Pharma
1 of 2
The research report Global Thalassemia Market and Competitive Landscape - 2020, provides comprehensive insights into the Thalassemia pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Thalassemia market size and drug sales. It also provides insights into Thalassemia epidemiology and late stage pipeline.

This research covers the following: Thalassemia treatment options, Thalassemia late stage clinical trials pipeline, Thalassemia prevalence by countries, Thalassemia market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).

Research Scope:
  • Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
  • Thalassemia pipeline: Find out drugs in clinical trials for the treatment of Thalassemia by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Thalassemia epidemiology: Find out the number of patients diagnosed (prevalence) with Thalassemia by countries
  • Thalassemia drugs: Identify key drugs marketed and prescribed for Thalassemia in the US, including trade name, molecule name, and company
  • Thalassemia drugs sales: Find out the sales value for Thalassemia drugs by countries
  • Thalassemia market valuations: Find out the market size for Thalassemia drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Thalassemia drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Thalassemia drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Thalassemia market
  • Develop in-depth knowledge of competition and markets
  • Analyze Thalassemia drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Thalassemia market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 2
1. Thalassemia Treatment Options

2. Thalassemia Pipeline Insights
2.1. Thalassemia Phase 3 Clinical Trials
2.2. Thalassemia Phase 2 Clinical Trials
2.3. Thalassemia Phase 1 Clinical Trials

3. Thalassemia Epidemiology Analysis by Countries

4. US Thalassemia Market Insights
4.1. Marketed Drugs for Thalassemia in US
4.2. US Thalassemia Market Size & Forecast
4.3. US Thalassemia Drugs Sales & Forecast
4.4. US Thalassemia Market Share Analysis

5. Germany Thalassemia Market Insights
5.1. Marketed Drugs for Thalassemia in Germany
5.2. Germany Thalassemia Market Size & Forecast
5.3. Germany Thalassemia Drugs Sales Forecast
5.4. Germany Thalassemia Market Share Analysis

6. France Thalassemia Market Insights
6.1. Marketed Drugs for Thalassemia in France
6.2. France Thalassemia Market Size & Forecast
6.3. France Thalassemia Product Sales Forecast
6.4. France Thalassemia Market Share Analysis

7. Italy Thalassemia Market Insights
7.1. Marketed Drugs for Thalassemia in Italy
7.2. Italy Thalassemia Market Size & Forecast
7.3. Italy Thalassemia Product Sales Forecast
7.4. Italy Thalassemia Market Share Analysis

8. Spain Thalassemia Market Insights
8.1. Marketed Drugs for Thalassemia in Spain
8.2. Spain Thalassemia Market Size & Forecast
8.3. Spain Thalassemia Product Sales Forecast
8.4. Spain Thalassemia Market Share Analysis

9. UK Thalassemia Market Insights
9.1. Marketed Drugs for Thalassemia in UK
9.2. UK Thalassemia Market Size & Forecast
9.3. UK Thalassemia Product Sales Forecast
9.4. UK Thalassemia Market Share Analysis

10. Europe Thalassemia Market Insights
10.1. Europe Thalassemia Market Size & Forecast
10.2. Europe Thalassemia Product Sales Forecast
10.3. Europe Thalassemia Market Share Analysis

11. Japan Thalassemia Market Insights
11.1. Marketed Drugs for Thalassemia in Japan
11.2. Japan Thalassemia Market Size & Forecast
11.3. Japan Thalassemia Product Sales Forecast
11.4. Japan Thalassemia Market Share Analysis

12. Global Thalassemia Market Insights
12.1. Global Thalassemia Market Size & Forecast
12.2. Global Thalassemia Product Sales Forecast
12.3. Global Thalassemia Market Share Analysis

13. Research Methodology

List of Tables
Table 1: Thalassemia Phase 3 Clinical Trials, Global, 2020
Table 2: Thalassemia Phase 2 Clinical Trials, Global, 2020
Table 3: Thalassemia Phase 1 Clinical Trials, Global, 2020
Table 4: Thalassemia Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Thalassemia in US, 2019
Table 6: US Thalassemia Market Size & Forecast ($mn), 2016 - 2024
Table 7: US Thalassemia Product Sales ($mn), 2016 - 2024
Table 8: US Thalassemia Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Thalassemia in Germany, 2019
Table 10: Germany Thalassemia Market Size & Forecast ($mn), 2016 - 2024
Table 11: Germany Thalassemia Product Sales ($mn), 2016 - 2024
Table 12: Germany Thalassemia Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Thalassemia in France, 2019
Table 14: France Thalassemia Market Size & Forecast ($mn), 2016 - 2024
Table 15: France Thalassemia Product Sales ($mn), 2016 - 2024
Table 16: France Thalassemia Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Thalassemia in Italy, 2019
Table 18: Italy Thalassemia Market Size & Forecast ($mn), 2016 - 2024
Table 19: Italy Thalassemia Product Sales ($mn), 2016 - 2024
Table 20: Italy Thalassemia Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Thalassemia in Spain, 2019
Table 22: Spain Thalassemia Market Size & Forecast ($mn), 2016 - 2024
Table 23: Spain Thalassemia Product Sales ($mn), 2016 - 2024
Table 24: Spain Thalassemia Market Events and Trends, 2016 - 2024
Table 25: Marketed Drugs for Thalassemia in UK, 2019
Table 26: UK Thalassemia Market Size & Forecast ($mn), 2016 - 2024
Table 27: UK Thalassemia Product Sales ($mn), 2016 - 2024
Table 28: UK Thalassemia Market Events and Trends, 2016 - 2024
Table 29: Europe Thalassemia Market Size & Forecast ($mn), 2016 - 2024
Table 30: Europe Thalassemia Product Sales ($mn), 2016 - 2024
Table 31: Marketed Drugs for Thalassemia in Japan, 2019
Table 32: Japan Thalassemia Market Size & Forecast ($mn), 2016 - 2024
Table 33: Japan Thalassemia Product Sales ($mn), 2016 - 2024
Table 34: Japan Thalassemia Market Events and Trends, 2016 - 2024
Table 35: Global Thalassemia Market Size & Forecast ($mn), 2016 - 2024
Table 36: Global Thalassemia Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Thalassemia Pipeline by Phase (%), Global, 2020
Figure 2: Thalassemia Prevalence by Countries, 2016 - 2024
Figure 3: US Thalassemia Market Size ($mn), 2016 - 2024
Figure 4: US Thalassemia Product Sales ($mn), 2016 - 2024
Figure 5: US Thalassemia Market Share by Drugs (%), 2019
Figure 6: US Thalassemia Market - Future Market Share (%), 2024
Figure 7: Germany Thalassemia Market Size ($mn), 2016 - 2024
Figure 8: Germany Thalassemia Product Sales ($mn), 2016 - 2024
Figure 9: Germany Thalassemia Market Share by Drugs (%), 2019
Figure 10: Germany Thalassemia Market - Future Market Share (%), 2024
Figure 11: France Thalassemia Market Size ($mn), 2016 - 2024
Figure 12: France Thalassemia Product Sales ($mn), 2016 - 2024
Figure 13: France Thalassemia Market Share by Drugs (%), 2019
Figure 14: France Thalassemia Market - Future Market Share (%), 2024
Figure 15: Italy Thalassemia Market Size ($mn), 2016 - 2024
Figure 16: Italy Thalassemia Product Sales ($mn), 2016 - 2024
Figure 17: Italy Thalassemia Market Share by Drugs (%), 2019
Figure 18: Italy Thalassemia Market - Future Market Share (%), 2024
Figure 19: Spain Thalassemia Market Size ($mn), 2016 - 2024
Figure 20: Spain Thalassemia Product Sales ($mn), 2016 - 2024
Figure 21: Spain Thalassemia Market Share by Drugs (%), 2019
Figure 22: Spain Thalassemia Market - Future Market Share (%), 2024
Figure 23: UK Thalassemia Market Size ($mn), 2016 - 2024
Figure 24: UK Thalassemia Product Sales ($mn), 2016 - 2024
Figure 25: UK Thalassemia Market Share by Drugs (%), 2019
Figure 26: UK Thalassemia Market - Future Market Share (%), 2024
Figure 27: Europe Thalassemia Market Size ($mn), 2016 - 2024
Figure 28: Europe Thalassemia Product Sales ($mn), 2016 - 2024
Figure 29: Europe Thalassemia Market Share by Drugs (%), 2019
Figure 30: Europe Thalassemia Market - Future Market Share (%), 2024
Figure 31: Japan Thalassemia Market Size ($mn), 2016 - 2024
Figure 32: Japan Thalassemia Product Sales ($mn), 2016 - 2024
Figure 33: Japan Thalassemia Market Share by Drugs (%), 2019
Figure 34: Japan Thalassemia Market - Future Market Share (%), 2024
Figure 35: Global Thalassemia Market Size ($mn), 2016 - 2024
Figure 36: Global Thalassemia Product Sales ($mn), 2016 - 2024
Figure 37: Global Thalassemia Market Share by Drugs (%), 2019
Figure 38: Global Thalassemia Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
Adroll
adroll